Federal Register / Vol. 65, No. 189 / Thursday, September 28, 2000 / Notices 58279

FDA regrets that it was unable to

publish this notice 15 days prior to the

October 6, 2000, Dental Products Panel

of the Medical Devices Advisory

Committee meeting. Because the agency

believes there is some urgency to bring

this issue to public discussion and

qualified members of the Dental

Products Panel of the Medical Devices

Advisory Committee were available at

this time, the Commissioner of Food

and Drugs concluded that it was in the

public interest to hold this meeting even

if there was not sufficient time for the

customary 15-day public notice.

Notice of this meeting is given under

the Federal Advisory Committee Act (5

U.S.C. app. 2).

Dated: September 20, 2000.

Bernard A. Schwetz,

Acting Deputy Commissioner.

[FR Doc. 00–24999 Filed 9–26–00; 8:45 am]

BILLING CODE 4160–01–F

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

Health Care Financing Administration

[Document Identifier: HCFA–10000]

Agency Information Collection

Activities: Proposed Collection;

Comment Request

AGENCY: Health Care Financing

Administration, DHHS. In compliance

with the requirement of section

3506(c)(2)(A) of the Paperwork

Reduction Act of 1995, the Health Care

Financing Administration (HCFA),

Department of Health and Human

Services, is publishing the following

summary of proposed collections for

public comment. Interested persons are

invited to send comments regarding this

burden estimate or any other aspect of

this collection of information, including

any of the following subjects: (1) The

necessity and utility of the proposed

information collection for the proper

performance of the agency’s functions;

(2) the accuracy of the estimated

burden; (3) ways to enhance the quality,

utility, and clarity of the information to

be collected; and (4) the use of

automated collection techniques or

other forms of information technology to

minimize the information collection

burden.

Type of Information Request:

Extension of a currently approved

collection; Title of Information

Collection: Medicare Consumer

Assessment Survey of Health Plan

Survey (CAHPS)—Fee for Service;

HCFA Form Number: HCFA–10000

(OMB approval #: 0938–0796); Use:

Under the Balanced Budget Act of 1997,

HCFA is required to provide general and

plan comparative information to

beneficiaries that will help them make

more informed health plan choices. A

CAHPS fee for service survey is needed

to provide information comparable to

those data collected from the CAHPS

managed care survey; Frequency:

Annually; Affected Public: Individuals

or households; Number of Respondents:

168,000; Total Annual Responses:

134,400; Total Annual Burden Hours:

44,800.

To obtain copies of the supporting

statement and any related forms for the

proposed paperwork collections

referenced above, access HCFA’s Web

Site address at http://www.hcfa.gov/

regs/prdact95.htm, or E-mail your

request, including your address, phone

number, OMB number, and HCFA

document identifier, to

Paperwork@hcfa.gov, or call the Reports

Clearance Office on (410) 786–1326.

Written comments and

recommendations for the proposed

information collections must be mailed

within 60 days of this notice directly to

the HCFA Paperwork Clearance Officer

designated at the following address:

HCFA, Office of Information Services,

Security and Standards Group, Division

of HCFA Enterprise Standards,

Attention: Julie Brown, Room N2–14–

26, 7500 Security Boulevard, Baltimore,

Maryland 21244–1850.

Dated: September 20, 2000.

John P. Burke III,

Reports Clearance Officer, Security and

Standards Group, Division of HCFA

Enterprise Standards.

[FR Doc. 00–24918 Filed 9–27–00; 8:45 am]

BILLING CODE 4120–03–P

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

Health Resources and Services

Administration Establishment of the

Advisory Committee on Organ

Transportation and Solicitation of

Nominations for Membership

AGENCY: Health Resources and Services

Administration (HRSA), HHS.

ACTION: Notice of establishment of the

Advisory Committee on Organ

Transplantation and Solicitation of

Nominations for Membership.

SUMMARY: Pursuant to 42 CFR 121.12

and Public Law 92–463, the Federal

Advisory Committee Act, as amended (5

U.S.C. Appendix 2), the Administrator,

HRSA, announces the establishment of

the Advisory Committee on Organ

Transplantation by the Secretary, HHS.

The Committee will advise the Secretary

through the Administrator, HRSA, on all

aspects of organ procurement,

allocation, and transplantation, and on

such other matters that the Secretary

determines.

Duration of this Committee is for two

years unless renewed by the Secretary,

HHS.

This notice also requests nominations

for membership on the Committee.

DATES: Nominations for members must

be received no later than 5 p.m. on

October 30, 2000.

ADDRESSES: You may mail or deliver

nominations to the following address:

Lynn Rothberg Wegman, M.P.A.,

Director, Division of Transplantation,

5600 Fishers Lane, Room 7C–22,

Rockville, MD 20857.

A request for a copy of the charter for

the Advisory Committee should be

submitted to: Miguel Kamat, Division of

Transplantation, 5600 Fishers Lane,

Room 7C–22, Rockville, MD 20857 or

may be viewed on the Division’s

website at www.hrsa.gov/osp/dot

FOR FURTHER INFORMATION CONTACT:

Lynn Rothberg Wegman, (301) 443–

7577.

SUPPLEMENTARY INFORMATION:

I. Background and Authority

As provided by 42 CFR 121.12 (64 FR

56661), the Secretary has established the

Advisory Committee on Organ

Transplantation. The Committee is

governed by the Federal Advisory

Committee Act (5 U.S.C. Appendix 2),

which sets forth standards for the

formation and use of advisory

committees.

The Advisory Committee shall advise

the Secretary, acting through the

Administrator, HRSA, on all aspects of

organ procurement, allocation, and

transplantation, and on such other

matters that the Secretary determines,

including:

(1) Proposed enforceable policies of

the Organ Procurement and

Transplantation Network (OPTN)

submitted for Secretarial approval.

(2) Organ allocation policies of the

OPTN.

(3) Other significant OPTN policies,

existing or proposed.

(4) The OPTN’s system of collecting,

disseminating and ensuring the validity,

accuracy, timeliness and usefulness of

data.

(5) The current state of knowledge

regarding transplantation.

(6) Additional scientific, medical,

public health, ethical, legal, coverage

and financing issues and socioeconomic

issues, including national and

international policies and